Primary cutaneous histoplasmosis in immunosuppressed patient.
D000666:Amphotericin B / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy; D006658:Histoplasma / Q000302:isolation & purification; D006660:Histoplasmosis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000469:parasitology; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000009:adverse effects*; D012876:Skin Diseases, Parasitic / Q000209:etiology* / Q000276:immunology
D000666:Amphotericin B; D011241:Prednisone